Originally published on Chacruna.net by Dr. Alli Feduccia

Clinical trials of MDMA, psilocybin, ketamine, and ayahuasca are offering a glimpse that the future may hold psychiatric treatments far different from daily drug prescriptions currently used for anxiety and addictive disorders. Research is only beginning to unravel how these experiences in altered states of consciousness produce large shifts in psychological functioning. Although a purely biochemical model is not inclusive of psycho-spiritual or transpersonal explanations, here I describe what scientific explorations are revealing about how the brain responds when … read full article.

Alli Feduccia, PhD
Alli Feduccia, PhD Administrator
Dr. Alli Feduccia is Co-Founder and Director of Psychedelic Support. She is a Neuropharmacologist who began researching MDMA in 2004. Alli currently works as a Clinical Data Scientist at MAPS Public Benefit Corporation on MDMA-assisted psychotherapy clinical trials and MAPS Therapy Training Program. Her work has instilled a deep interest for understanding the therapeutic applications of psychedelics for mind-body-spirit health.

Subscribe to Psychedelic Support

We'll keep you up to date with the latest in Psychedelic Therapy and Research

You have Successfully Subscribed!

Share This

INTEGRATION EVENTS

TRAINING EVENTS

WHO WE ARE
KEEP IN TOUCH